SCHEMBL31667255

SCHEMBL31667255

O=C1c2ccc(Br)cc2CN1Cc1ccc2[nH]c(=O)oc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ IL4I1 Q96RQ9 1/20 0.38
▸ ALPL P05186 1/20 0.37
▸ NOS1 P29475 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ ENPP2 Q13822 1/20 0.36
▸ ATXN2 Q99700 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CHEK1 O14757 1/20 0.34
▸ PRMT5 O14744 1/20 0.34
▸ WDR77 Q9BQA1 1/20 0.34
▸ HTR1A P08908 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31667499 0.87 NOS1 (0.52) MEN1KMT2AIL4I1ALPLNOS1
SCHEMBL31667533 0.85 HDAC1 (0.47) MEN1KMT2AIL4I1NOS1TSHR
SCHEMBL32686852 0.84 HTR1A (0.44) MEN1KMT2AIL4I1ALPLNOS1
SCHEMBL31667316 0.84 SMN1; SMN2 (0.44) MEN1KMT2AALPLTSHR
SCHEMBL31667283 0.81 HTR1A (0.42) MEN1KMT2AALPLLMNAMAPT
SCHEMBL31667028 0.76 IL4I1 (0.43) MEN1KMT2AIL4I1ALPLNOS1
SCHEMBL3853977 0.74 MAPK1 (0.44) MEN1KMT2AHDAC1HDAC7LMNA
SCHEMBL2026192 0.74 MEN1 (0.45) MEN1KMT2AHDAC1HDAC7LMNA
SCHEMBL31667651 0.74 ESR1 (0.46) MEN1KMT2AHDAC1HDAC7PRMT5
SCHEMBL1500111 0.74 HDAC1 (0.49) MEN1KMT2ATSHRHDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 — — US disclosed
EP-4590674-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2025-07-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 MEN1 2008/4885KMT2A 2737/4885IL4I1 2872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback